Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott T Aaronson

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
The Journal of ECT|April 4, 2018
Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive DisorderBrian C Kavanaugh, Scott T Aaronson, Gregory N Clarke, et al.
Journal of Affective Disorders|February 18, 2026
Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trialA John Rush, Harold A Sackeim, Ying-Chieh Lisa Lee, et al.
Journal of Child and Adolescent Psychopharmacology|April 22, 2020
Treatment-Resistant Depression in Adolescents: Clinical Features and Measurement of Treatment ResistanceJeffrey R Strawn, Scott T Aaronson, Ahmed Z Elmaadawi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 12, 2020
Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trialPaul E Croarkin, Ahmed Z Elmaadawi, Scott T Aaronson, et al.
Journal of Child and Adolescent Psychopharmacology|December 24, 2024
A Multisite, 6-Month, Open-Label Study of Maintenance Transcranial Magnetic Stimulation for Adolescents with Treatment-Resistant DepressionJuan F Garzon, Ahmed Z Elmaadawi, Scott T Aaronson, et al.
Journal of Psychiatric Research|April 12, 2019
The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF)Harold A Sackeim, Scott T Aaronson, Mark T Bunker, et al.
Journal of Affective Disorders|March 24, 2025
Characterizing the effects of vagus nerve stimulation on symptom improvement in markedly treatment-resistant major depressive disorder: A RECOVER trial reportHarold A Sackeim, Charles R Conway, Scott T Aaronson, et al.
Depression and Anxiety|June 13, 2012
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practiceLinda L Carpenter, Philip G Janicak, Scott T Aaronson, et al.
Brain Stimulation|December 29, 2015
Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot StudyNoah S Philip, David L Dunner, Sheila M Dowd, et al.
Psychological Medicine|January 5, 2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of lifeHarold A Sackeim, A John Rush, Teresa Greco, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
The Journal of ECT|April 4, 2018
Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive DisorderBrian C Kavanaugh, Scott T Aaronson, Gregory N Clarke, et al.
Journal of Affective Disorders|February 18, 2026
Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trialA John Rush, Harold A Sackeim, Ying-Chieh Lisa Lee, et al.
Journal of Child and Adolescent Psychopharmacology|April 22, 2020
Treatment-Resistant Depression in Adolescents: Clinical Features and Measurement of Treatment ResistanceJeffrey R Strawn, Scott T Aaronson, Ahmed Z Elmaadawi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 12, 2020
Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trialPaul E Croarkin, Ahmed Z Elmaadawi, Scott T Aaronson, et al.
Journal of Child and Adolescent Psychopharmacology|December 24, 2024
A Multisite, 6-Month, Open-Label Study of Maintenance Transcranial Magnetic Stimulation for Adolescents with Treatment-Resistant DepressionJuan F Garzon, Ahmed Z Elmaadawi, Scott T Aaronson, et al.
Journal of Psychiatric Research|April 12, 2019
The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF)Harold A Sackeim, Scott T Aaronson, Mark T Bunker, et al.
Journal of Affective Disorders|March 24, 2025
Characterizing the effects of vagus nerve stimulation on symptom improvement in markedly treatment-resistant major depressive disorder: A RECOVER trial reportHarold A Sackeim, Charles R Conway, Scott T Aaronson, et al.
Depression and Anxiety|June 13, 2012
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practiceLinda L Carpenter, Philip G Janicak, Scott T Aaronson, et al.
Brain Stimulation|December 29, 2015
Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot StudyNoah S Philip, David L Dunner, Sheila M Dowd, et al.
Psychological Medicine|January 5, 2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of lifeHarold A Sackeim, A John Rush, Teresa Greco, et al.
Pageof 7